These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27603532)

  • 1. Mesenchymal Stromal Cell-Based Therapies for Chronic Lung Disease of Prematurity.
    Strueby L; Thébaud B
    Am J Perinatol; 2016 Sep; 33(11):1043-9. PubMed ID: 27603532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of stem cells in bronchopulmonary dysplasia.
    O'Reilly M; Thébaud B
    Semin Perinatol; 2013 Apr; 37(2):79-84. PubMed ID: 23582961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell experiments moves into clinic: new hope for children with bronchopulmonary dysplasia.
    Pawelec K; Gładysz D; Demkow U; Boruczkowski D
    Adv Exp Med Biol; 2015; 839():47-53. PubMed ID: 25252892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.
    Lesage F; Thébaud B
    Semin Perinatol; 2018 Nov; 42(7):453-458. PubMed ID: 30376986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.
    Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stromal Cell Therapy for Respiratory Complications of Extreme Prematurity.
    Thébaud B
    Am J Perinatol; 2018 May; 35(6):566-569. PubMed ID: 29694998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based therapies for neonatal lung disease.
    O'Reilly M; Thébaud B
    Cell Tissue Res; 2017 Mar; 367(3):737-745. PubMed ID: 27770256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia.
    Moreira A; Winter C; Joy J; Winter L; Jones M; Noronha M; Porter M; Quim K; Corral A; Alayli Y; Seno T; Mustafa S; Hornsby P; Ahuja S
    Stem Cells Transl Med; 2020 Feb; 9(2):221-234. PubMed ID: 31774626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors, stem cells and bronchopulmonary dysplasia.
    Alphonse RS; Thébaud B
    Neonatology; 2011; 99(4):326-37. PubMed ID: 21701205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils.
    Möbius MA; Thébaud B
    Paediatr Respir Rev; 2016 Sep; 20():33-41. PubMed ID: 27425012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy.
    Pierro M; Ciarmoli E; Thébaud B
    Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung injury in preterm neonates: the role and therapeutic potential of stem cells.
    Alphonse RS; Rajabali S; Thébaud B
    Antioxid Redox Signal; 2012 Oct; 17(7):1013-40. PubMed ID: 22400813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells and Bronchopulmonary Dysplasia - The five questions: Which cells, when, in which dose, to which patients via which route?
    Mueller M; Kramer BW
    Paediatr Respir Rev; 2017 Sep; 24():54-59. PubMed ID: 28162941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.
    Pierro M; Thébaud B; Soll R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011932. PubMed ID: 29125893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung mesenchymal stromal cells in development and disease: to serve and protect?
    Collins JJ; Thébaud B
    Antioxid Redox Signal; 2014 Nov; 21(13):1849-62. PubMed ID: 24350665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia.
    Pierro M; Ionescu L; Montemurro T; Vadivel A; Weissmann G; Oudit G; Emery D; Bodiga S; Eaton F; Péault B; Mosca F; Lazzari L; Thébaud B
    Thorax; 2013 May; 68(5):475-84. PubMed ID: 23212278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of bronchopulmonary dysplasia. The term rat models.
    O'Reilly M; Thébaud B
    Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(12):L948-58. PubMed ID: 25305248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.